Leuko is developing the first non-invasive white blood cell device. White blood cell assessment is the first-line indicator for various medically relevant situations, ranging from chemotherapy management to the detection of life-threatening infections worldwide.

Medical Devices

Leuko

Leuko's headquarters in Boston, MA, United States

The Madrid office focuses on healthcare innovation through data science and deep learning technologies.

Madrid

Carlos Castro Gonzalez

Alvaro Sanchez - Ferro

Aurelien Bourquard

Ian Butterworth

Paul Hartung

Amy Salzhauer

The Engineering Team at Leuko is responsible for designing, developing, and optimizing the company's non-invasive white blood cell device. This team integrates advanced machine learning algorithms, robust data analysis, innovative software solutions, and cutting-edge hardware to ensure accurate and reliable white blood cell assessments, enhancing patient care and healthcare outcomes worldwide.

Engineering Team

The Leadership Team at Leuko drives the strategic vision and operational execution of the company, ensuring alignment between clinical innovation and technological advancement. Comprising top executives including the CEO, CTO, and Chief Medical Officers, the team collaborates to develop groundbreaking non-invasive solutions for white blood cell assessment, guiding the organization in navigating regulatory landscapes, optimizing research initiatives, and fostering partnerships to enhance patient care globally.

Leuko

Org chart

Board & advisors

Teams

Engineering Team

Leadership Team

Offices

Leuko

Org chart

Board & advisors

Teams

Engineering Team

Leadership Team

Offices

Related companies